Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

NCT01039103 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Exacerbation of Remitting Relapsing Multiple Sclerosis
Clinically Isolated Syndrome

Interventions

DRUG: PEG-liposomal prednisolone sodium phosphate
DRUG: Methylprednisolone

Sponsor

Lakefront Biotherapeutics NV